Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adimab LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Adimab LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adimab LLC, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Adimab Raises US$13.8 Million In Series F Financing 12
Partnerships 14
Adimab Enters into Agreement with Boehringer Ingelheim 14
Adimab Enters into Drug Discovery Agreement with Kodiak Sciences 15
Adimab Enters into Drug Discovery Agreement with Takeda Pharma 16
iTeos Therapeutics Enters into Agreement with Adimab 17
Adimab Enters into Agreement with The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center 18
Adimab Enters into Research Agreement with Kite Pharma 19
Adimab Enters into Discovery Agreement with Celgene 20
Adimab Enters into Agreement with Sanofi for Bispecific Antibody 21
Adimab Enters into Agreement with Acceleron Pharma 22
Adimab Enters into Agreement with Oncothyreon 23
Adimab Enters into Agreement with Surface Oncology 24
Adimab Enters into Agreement with Potenza Therapeutics 25
Five Prime Therapeutics Enters Into Research Agreement With Adimab 26
Jounce Therapeutics Enters Into Research Agreement With Adimab 27
Alector Enters Into Research Agreement With Adimab 28
Adimab Enters Into Agreement With Celgene To Discover Therapeutic Antibodies 29
Adimab Expands Agreement with Innovent Biologics 30
GlaxoSmithKline Expands its Partnership with Adimab 31
Adimab Expands Collaboration With Merck To Discover Human Antibody Candidates 32
Adimab Enters Into Antibody Discovery Agreement With Kyowa Hakko Kirin 33
Adimab Enters Into Co-Development Agreement With Gilead Sciences 34
Licensing Agreements 35
Eli Lilly Enters into Licensing Agreement with Adimab 35
Arsanis Enters into Licensing Agreement with Adimab 36
Kite Pharma Exercises Option for Licensing Agreement with Adimab 37
Jounce Therapeutics Exercises Option for Licensing Agreement with Adimab 38
Adimab Enters into Licensing Agreement with Merck 39
Adimab Enters Into Licensing Agreement With Novo Nordisk 40
GlaxoSmithKline Enters Into Licensing Agreement With Adimab 41
Eli Lilly Exercises Option for Licensing Agreement with Adimab for Multiple Bispecific Antibodies 42
Mersana Therapeutics Amends its Licensing Agreement with Adimab 43
Adimab LLC – Key Competitors 44
Adimab LLC – Key Employees 45
Adimab LLC – Locations And Subsidiaries 46
Head Office 46
Recent Developments 47
Other Significant Developments 47
Aug 09, 2018: Ebola virus experts discover powerful, new approach for future therapeutics 47
Jan 11, 2018: Adimab Initiates Update on Clinical Progression of Partner Programs 49
Jan 08, 2018: Adimab Provides Year-End Update on 2017 Partnership Activities 50
Jan 10, 2017: Adimab Provides Annual Update on 2016 Partnerships and Milestones 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52
Adimab LLC, Pharmaceuticals & Healthcare, Key Facts 2
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adimab LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adimab LLC, Deals By Therapy Area, 2012 to YTD 2018 9
Adimab LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adimab Raises US$13.8 Million In Series F Financing 12
Adimab Enters into Agreement with Boehringer Ingelheim 14
Adimab Enters into Drug Discovery Agreement with Kodiak Sciences 15
Adimab Enters into Drug Discovery Agreement with Takeda Pharma 16
iTeos Therapeutics Enters into Agreement with Adimab 17
Adimab Enters into Agreement with The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center 18
Adimab Enters into Research Agreement with Kite Pharma 19
Adimab Enters into Discovery Agreement with Celgene 20
Adimab Enters into Agreement with Sanofi for Bispecific Antibody 21
Adimab Enters into Agreement with Acceleron Pharma 22
Adimab Enters into Agreement with Oncothyreon 23
Adimab Enters into Agreement with Surface Oncology 24
Adimab Enters into Agreement with Potenza Therapeutics 25
Five Prime Therapeutics Enters Into Research Agreement With Adimab 26
Jounce Therapeutics Enters Into Research Agreement With Adimab 27
Alector Enters Into Research Agreement With Adimab 28
Adimab Enters Into Agreement With Celgene To Discover Therapeutic Antibodies 29
Adimab Expands Agreement with Innovent Biologics 30
GlaxoSmithKline Expands its Partnership with Adimab 31
Adimab Expands Collaboration With Merck To Discover Human Antibody Candidates 32
Adimab Enters Into Antibody Discovery Agreement With Kyowa Hakko Kirin 33
Adimab Enters Into Co-Development Agreement With Gilead Sciences 34
Eli Lilly Enters into Licensing Agreement with Adimab 35
Arsanis Enters into Licensing Agreement with Adimab 36
Kite Pharma Exercises Option for Licensing Agreement with Adimab 37
Jounce Therapeutics Exercises Option for Licensing Agreement with Adimab 38
Adimab Enters into Licensing Agreement with Merck 39
Adimab Enters Into Licensing Agreement With Novo Nordisk 40
GlaxoSmithKline Enters Into Licensing Agreement With Adimab 41
Eli Lilly Exercises Option for Licensing Agreement with Adimab for Multiple Bispecific Antibodies 42
Mersana Therapeutics Amends its Licensing Agreement with Adimab 43
Adimab LLC, Key Competitors 44
Adimab LLC, Key Employees 45
List of Figures
Adimab LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adimab LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adimab LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer